Clinical Trials Optimization Using Real-World Data for Enhanced Post-Market Surveillance in 2025
The Evolution of Post-Market Surveillance (PMS) with Data Collection Clinical Trials Optimization is moving toward a continuous model that seamlessly integrates pre-market studies with robust post-market surveillance (PMS). The key trend for 2025 is the efficient use of Real-World Data (RWD) collected outside of traditional randomized controlled trials. This includes data harvested from...
0 Комментарии 0 Поделились 85 Просмотры 0 предпросмотр